Study: US Abortion Restrictions Restrict Miscarriage Options

Access to essential miscarriage care in the US has become significantly more challenging in states with abortion restrictions following the Dobbs v. Jackson Women's Health Organization decision in June 2022. Research published in the Journal of the American Medical Association highlights a fracturing of pregnancy care along state lines, making it harder for individuals to receive timely and appropriate treatment for miscarriages.

Study findings revealed that in states with abortion bans enacted after Dobbs, there was an increase in expectant management, meaning more patients were advised to wait for their miscarriages to resolve naturally. Concurrently, there was a decrease in medication management, with fewer individuals being prescribed standard-of-care medications. For those prescribed medication, a rise in misoprostol-only treatments was observed, which, while safe, is not the US standard and may prolong discomfort and recovery.

Lead author Maria Rodriguez of Oregon Health & Science University emphasized that spontaneous abortion, or miscarriage, requires the same treatment options as induced abortion. The study, which examined over 123,000 privately insured individuals, suggests that the disparities in care are likely even greater for those without private insurance, such as individuals on Medicaid, who are at higher risk for severe maternal morbidity.

Experts warn that mismanaging miscarriage care can lead to dangerous infections, reduced fertility, and significant emotional trauma. Restrictions on providers and insurers may further deter the prescription and coverage of mifepristone, a key medication in standard miscarriage management. This creates a situation where fewer people receive the recommended care, underscoring the interconnectedness of reproductive healthcare services.